In-person cancer annual meetings during the COVID-19 pandemic: What you need to know

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Professional societies are implementing measures to limit transmission of SARS-CoV-2 at conferences, as oncology groups reconvene in-person annual meetings for the first time since early 2020. The American Society of Clinical Oncology will require proof of vaccination, encourage indoor masking, and provide masks onsite—regardless of mandates and regulations—at its upcoming annual meeting June 3-7 in...

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Matthew Bin Han Ong
Matthew Bin Han Ong
Table of Contents

YOU MAY BE INTERESTED IN

As NCI and NIH funding is being deliberated in Congress, this year’s 2025 AACR Cancer Progress Report had an unequivocal message: With 20 new anticancer therapeutics, new uses for eight previously approved anticancer therapeutics, two new early detection tools, and several AI-powered diagnostics approved over the span of just one year, cancer research funding yields a good return on investment. 
Matthew Bin Han Ong
Matthew Bin Han Ong

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login